Gestational diabetes is characterized by reduced mitochondrial protein expression and altered calcium signaling proteins in skeletal muscle

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Boyle, Kristen E ^a   Hwang, Hyonson ^b   Janssen, Rachel C ^a   DeVente, James M ^c   Barbour, Linda A ^a   Hernandez, Teri L ^a   Mandarino, Lawrence J ^d,e   Lappas, Martha ^f,g   Friedman, Jacob E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

^e Mayo Clinic in Arizona   (United States)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 SYNTROPHIN; CALCINEURIN; CALCINEURIN A; CYTOCHROME C OXIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPOCORTIN 4; MITOCHONDRIAL PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SYNTROPHIN; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; ADENYLATE KINASE; MUSCLE PROTEIN;

ADULT; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; MITOCHONDRIAL BIOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PHYSICAL ACTIVITY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECTUS ABDOMINIS MUSCLE; RISK FACTOR; VALIDATION STUDY; ELECTRON TRANSPORT; ENZYMOLOGY; GLUCOSE TOLERANCE TEST; METABOLISM; MITOCHONDRION; PHOSPHORYLATION; PREGNANCY; PROTEOMICS; SKELETAL MUSCLE;

ADENYLATE KINASE; ADULT; CALCIUM SIGNALING; DIABETES, GESTATIONAL; ELECTRON TRANSPORT; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; OBESITY; PHOSPHORYLATION; PREGNANCY; PROTEOMICS;

EID: 84925376523     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106872     Document Type: Article

References (60)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307: 491-497.doi:10.1001/jama.2012.39.
2. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, et al. (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33: 676-682.doi:10.2337/dc09-1848.
3. Heerwagen MJR, Miller MR, Barbour LA, Friedman JE (2010) Maternal obesity and fetal metabolic programming: A fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol 299: R711-R722.doi:10.1152/ajpregu.00310.2010.
4. Saydah SH, Chandra A, Eberhardt MS (2005) Pregnancy experience among women with and without gestational diabetes in the U.S., 1995 National Survey Of Family Growth. Diabetes Care 28: 1035-1040.
5. Bentley-Lewis R, Powe C, Ankers E, Wenger J, Ecker J, et al. (2014) Effect of Race/Ethnicity on Hypertension Risk Subsequent to Gestational Diabetes Mellitus. Am J Cardiol.doi:10.1016/j.amjcard.2014.01.411.
6. Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, et al. (2014) Diagnostic thresholds for gestational diabetes and their impact on pregnancy outcomes: A systematic review. Diabet Med 31: 319-331.doi:10.1111/dme.12357.
7. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, et al. (2007) Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30 Suppl 2: S112-S119.doi:10.2337/dc07-s202.
8. Barbour LA, McCurdy CE, Hernandez TL, Friedman JE (2011) Chronically increased S6K1 is associated with impaired IRS1 signaling in skeletal muscle of GDM women with impaired glucose tolerance postpartum. J Clin Endocrinol Metab 96: 1431-1441.doi:10.1210/jc.2010-2116.
9. Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: A systematic review. Diabetes Care 25: 1862-1868.
10. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, et al. (2008) Prevention of diabetes in women with a history of gestational diabetes: Effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 93: 4774-4779.doi:10.1210/jc.2008-0772.
11. Ruchat S-M, Mottola MF (2013) The important role of physical activity in the prevention and management of gestational diabetes mellitus. Diabetes Metab Res Rev 29: 334-346.doi:10.1002/dmrr.2402.
12. Catalano PM, Nizielski SE, Shao J, Preston L, Qiao L, et al. (2002) Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: Relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab 282: E522-E533.doi:10.1152/ajpendo.00124.2001.
13. Herrera E (2000) Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 54 Suppl 1: S47-S51.
14. Okereke NC, Huston-Presley L, Amini SB, Kalhan S, Catalano PM (2004) Longitudinal changes in energy expenditure and body composition in obese women with normal and impaired glucose tolerance. Am J Physiol Endocrinol Metab 287: E472-E479.doi:10.1152/ajpendo.00589.2003.
15. Catalano PM, Huston L, Amini SB, Kalhan SC (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180: 903-916.
16. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulindependent (type II) diabetes mellitus. J Clin Invest 76: 149-155.doi:10.1172/JCI111938.
17. Ghanassia E, Brun J-F, Mercier J, Raynaud E (2007) Oxidative mechanisms at rest and during exercise. Clin Chim Acta 383: 1-20.doi:10.1016/j.cca.2007.04.006.
18. Dabelea D, Crume T (2011) Maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 60: 1849-1855.doi:10.2337/db11-0400.
19. Hwang H, Bowen BP, Lefort N, Flynn CR, De Filippis EA, et al. (2010) Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes 59: 33-42.doi:10.2337/db09-0214.
20. Carpenter MW, Coustan DR (1982) Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144: 768-773.
21. Tanner CJ, Barakat HA, Dohm GL, Pories WJ, MacDonald KG, et al. (2002) Muscle fiber type is associated with obesity and weight loss. Am J Physiol Endocrinol Metab 282: E1191-E1196.doi:10.1152/ajpendo.00416.2001.
22. McCurdy CE, Bishop JM, Williams SM, Grayson BE, Smith MS, et al. (2009) Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 119: 323-335.doi:10.1172/JCI32661.
23. Reece EA, Leguizamón G, Wiznitzer A (2009) Gestational diabetes: The need for a common ground. Lancet 373: 1789-1797.doi:10.1016/S0140-6736(09)60515-8.
24. Lovering RM, Anderson LD (2008) Architecture and fiber type of the pyramidalis muscle. Anat Sci Int 83: 294-297.doi:10.1111/j.1447-073X.2007.00226.x.
25. Colomiere M, Permezel M, Lappas M (2010) Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue. J Mol Endocrinol 44: 213-223.doi:10.1677/JME-09-0091.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
27. Frazier AE, Thorburn DR (2012) Biochemical analyses of the electron transport chain complexes by spectrophotometry. Methods Mol Biol 837: 49-62.doi:10.1007/978-1-61779-504-6-4.
28. Boyle KE, Newsom SA, Janssen RC, Lappas M, Friedman JE (2013) Skeletal muscle MnSOD, mitochondrial complex II, and SIRT3 enzyme activities are decreased in maternal obesity during human pregnancy and gestational diabetes mellitus. J Clin Endocrinol Metab 98: E1601-E1609.doi:10.1210/jc.2013-1943.
29. Reznick RM, Shulman GI (2006) The role of AMP-activated protein kinase in mitochondrial biogenesis. J Physiol (Lond) 574: 33-39.doi:10.1113/jphysiol. 2006.109512.
30. Ruderman NB, Carling D, Prentki M, Cacicedo JM (2013) AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 123: 2764-2772.doi:10.1172/JCI67227.
31. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, et al. (2003) Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 300: 1140-1142.doi:10.1126/science.1082889.
32. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, et al. (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7: 45-56.doi:10.1016/j.cmet.2007.10.013.
33. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, et al. (2009) Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 119: 573-581.doi:10.1172/JCI37048.
34. Nair KS, Bigelow ML, Asmann YW, Chow LS, Coenen-Schimke JM, et al. (2008) Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 57: 1166-1175.doi:10.2337/db07-1556.
35. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsøe R, et al. (2007) Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50: 790-796.doi:10.1007/s00125-007-0594-3.
36. Buchanan TA, Xiang AH (2005) Gestational diabetes mellitus. J Clin Invest 115: 485-491.doi:10.1172/JCI24531.
37. Buchanan TA, Xiang AH, Page KA (2012) Gestational diabetes mellitus: Risks and management during and after pregnancy. Nat Rev Endocrinol 8: 639-649.doi:10.1038/nrendo.2012.96.
38. Berchtold MW, Brinkmeier H, Müntener M (2000) Calcium ion in skeletal muscle: Its crucial role for muscle function, plasticity, and disease. Physiol Rev 80: 1215-1265.
39. Park S, Scheffler TL, Rossie SS, Gerrard DE (2013) AMPK activity is regulated by calcium-mediated protein phosphatase 2A activity. Cell Calcium 53: 217-223.doi:10.1016/j.ceca.2012.12.001.
40. Park S, Scheffler TL, Gerrard DE (2011) Chronic high cytosolic calcium decreases AICAR-induced AMPK activity via calcium/calmodulin activated protein kinase II signaling cascade. Cell Calcium 50: 73-83.doi:10.1016/j.ceca.2011.05.009.
41. Constantin B (2014) Dystrophin complex functions as a scaffold for signalling proteins. Biochim Biophys Acta 1838: 635-642.doi:10.1016/j.bbamem. 2013.08.023.
42. Campbell KP, Kahl SD (1989) Association of dystrophin and an integral membrane glycoprotein. Nature 338: 259-262.doi:10.1038/338259a0.
43. Vandebrouck A, Sabourin J, Rivet J, Balghi H, Sebille S, et al. (2007) Regulation of capacitative calcium entries by alpha1-syntrophin: Association of TRPC1 with dystrophin complex and the PDZ domain of alpha1-syntrophin. FASEB J 21: 608-617.doi:10.1096/fj.06-6683com.
44. Mallouk N, Jacquemond V, Allard B (2000) Elevated subsarcolemmal Ca2+ in mdx mouse skeletal muscle fibers detected with Ca2+-activated K+ channels. Proc Natl Acad Sci USA 97: 4950-4955.
45. Sabourin J, Lamiche C, Vandebrouck A, Magaud C, Rivet J, et al. (2009) Regulation of TRPC1 and TRPC4 cation channels requires an alpha1-syntrophin-dependent complex in skeletal mouse myotubes. J Biol Chem 284: 36248-36261.doi:10.1074/jbc.M109.012872.
46. Sabourin J, Harisseh R, Harnois T, Magaud C, Bourmeyster N, et al. (2012) Dystrophin/a1-syntrophin scaffold regulated PLC/PKC-dependent store-operated calcium entry in myotubes. Cell Calcium 52: 445-456.doi:10.1016/j.ceca.2012.08.003.
47. Murray J, Zhang B, Taylor SW, Oglesbee D, Fahy E, et al. (2003) The subunit composition of the human NADH dehydrogenase obtained by rapid one-step immunopurification. J Biol Chem 278: 13619-13622.doi:10.1074/jbc.C300064200.
48. Suhane S, Kanzaki H, Arumugaswami V, Murali R, Ramanujan VK (2013) Mitochondrial NDUFS3 regulates the ROS-mediated onset of metabolic switch in transformed cells. Biol Open 2: 295-305.doi:10.1242/bio.20133244.
49. Liu H-Y, Liao P-C, Chuang K-T, Kao M-C (2011) Mitochondrial targeting of human NADH dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2) and its association with early-onset hypertrophic cardiomyopathy and encephalopathy. J Biomed Sci 18: 29.doi:10.1186/1423-0127-18-29.
50. Mulvey C, Harno E, Keenan A, Ohlendieck K (2005) Expression of the skeletal muscle dystrophin-dystroglycan complex and syntrophin-nitric oxide synthase complex is severely affected in the type 2 diabetic Goto-Kakizaki rat. Eur J Cell Biol 84: 867-883.doi:10.1016/j.ejcb.2005.06.007.
51. Gerke V, Creutz CE, Moss SE (2005) Annexins: Linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461.doi:10.1038/nrm1661.
52. Jeon Y-J, Kim D-H, Jung H, Chung SJ, Chi S-W, et al. (2010) Annexin A4 interacts with the NF-kappaB p50 subunit and modulates NF-kappaB transcriptional activity in a Ca2+-dependent manner. Cell Mol Life Sci 67: 2271-2281.doi:10.1007/s00018-010-0331-9.
53. Friedman JE, Kirwan JP, Jing M, Presley L, Catalano PM (2008) Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum. Diabetes 57: 606-613.doi:10.2337/db07-1356.
54. Oliva K, Barker G, Rice GE, Bailey MJ, Lappas M (2013) 2D-DIGE to identify proteins associated with gestational diabetes in omental adipose tissue. J Endocrinol 218: 165-178.doi:10.1530/JOE-13-0010.
55. Rusnak F, Mertz P (2000) Calcineurin: Form and function. Physiol Rev 80: 1483-1521.
56. Long YC, Glund S, Garcia-Roves PM, Zierath JR (2007) Calcineurin regulates skeletal muscle metabolism via coordinated changes in gene expression. J Biol Chem 282: 1607-1614.doi:10.1074/jbc.M609208200.
57. Guha M, Srinivasan S, Biswas G, Avadhani NG (2007) Activation of a novel calcineurin-mediated insulin-like growth factor-1 receptor pathway, altered metabolism, and tumor cell invasion in cells subjected to mitochondrial respiratory stress. J Biol Chem 282: 14536-14546.doi:10.1074/jbc.M611693200.
58. Battiprolu PK, Gillette TG, Wang ZV, Lavandero S, Hill JA (2010) Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets. Drug Discov Today Dis Mech 7: E135-e143.doi:10.1016/j.ddmec.2010.08.001.
59. Fitts RH (2011) New insights on sarcoplasmic reticulum calcium regulation in muscle fatigue. J Appl Physiol 111: 345-346.doi:10.1152/japplphysiol. 00720.2011.
60. Rullman E, Andersson DC, Melin M, Reiken S, Mancini DM, et al. (2013) Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure. J Heart Lung Transplant 32: 925-929.doi:10.1016/j.healun.2013.06.026.